Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Keytruda
Pembrolizumab 50mg
Powder for infusion
Merck Sharp & Dohme (New Zealand) Limited
MSD International GmbH, Innishannon, Ireland
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Perjeta
Pertuzumab 420mg equivalent to 30mg/mL
Concentrate for infusion
Roche Products (NZ) Limited
Roche Diagnostics GmbH, Mannheim Germany
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Rabipur
Rabies vaccine 2.5IU
Powder for injection
GlaxoSmithKline (NZ) Limited
GSK Vaccines GmbH, Marburg, Germany
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Salazopyrin-EN
Sulfasalazine 500mg
Enteric coated tablet
Pfizer New Zealand Limited
Recipharm Uppsala AB, Uppsala, Sweden
|
Dated this 31st day of July 2018.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
Gazette.govt.nz